Efficient Method to Dissociate Induced Pluripotent Stem Cell-Derived Cardiomyocyte Aggregates into Single Cells
Emiko Ito1,2, Shigeru Miyagawa1, Yoshinori Yoshida3
1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Insights
Researchers developed a new method to efficiently dissociate large numbers of induced pluripotent stem cell-derived cardiomyocyte aggregates for cell therapy. This advance aids myocardial regeneration by providing more cells for transplantation after heart damage.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- The adult human heart has billions of cardiomyocytes that lack self-renewal capacity.
- Significant cardiomyocyte loss occurs in conditions like myocardial infarction and dilated cardiomyopathy.
- Induced pluripotent stem cells (iPSCs) offer potential for cell therapy due to their differentiation capabilities.
Purpose of the Study:
- To develop an efficient method for dissociating large numbers of iPSC-derived cardiomyocyte aggregates.
- To facilitate the generation of sufficient cardiomyocytes for myocardial regeneration therapy.
Main Methods:
- Described a novel method for the simultaneous dissociation of multiple cardiomyocyte aggregates.
- Focused on optimizing the process for large-scale production of iPSC-derived cardiomyocytes.
Main Results:
- Successfully developed a method for efficient dissociation of iPSC-derived cardiomyocyte aggregates.
- The method enables the simultaneous processing of multiple aggregates, increasing cell yield.
Conclusions:
- The described method provides a scalable approach for generating cardiomyocytes for cell-based therapies.
- This technique is crucial for advancing myocardial regeneration strategies by overcoming cell quantity limitations.
Abstract:
The human adult heart consists of approximately four billion cardiomyocytes, which do not possess self-renewal abilities. Severe myocardial infarction and dilated cardiomyopathy result in the loss of more than a billion cardiomyocytes. Induced pluripotent stem cells (iPSCs) can differentiate into various types of cells. Due to this ability, these cells could potentially serve as a new resource for cell therapy. Many studies have utilized cardiomyocytes derived from iPSCs for myocardial regeneration therapy. To obtain large number of cardiomyocytes for transplantation, we need to develop effective methods that would allow us to dissociate multiple cardiomyocyte aggregates simultaneously. Here, we describe a method to efficiently dissociate large number of iPSC-derived cardiomyocyte aggregates.
More Related Videos
06:28Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells
Published on: September 25, 2016
08:06Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020